Geron, Merck Research Laboratories other research news

GERN published the cloning of the catalytic portion of human telomerase, the enzyme that maintains the ends of chromosomes to enable

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE